These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20839951)

  • 21. Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.
    Zervos MJ; Freeman K; Vo L; Haque N; Pokharna H; Raut M; Kim M
    J Clin Microbiol; 2012 Feb; 50(2):238-45. PubMed ID: 22116149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of question and answer session.
    Segreti J
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S36-8. PubMed ID: 19560674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of patients with skin and soft tissue infections. Results from the STRAMA survey of diagnoses and prescriptions among general practitioners].
    André M; Eriksson M; Odenholt I
    Lakartidningen; 2006 Oct 18-24; 103(42):3165-7. PubMed ID: 17111984
    [No Abstract]   [Full Text] [Related]  

  • 24. Skin and soft tissue infections. Introduction.
    Gould IM; Esposito S
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S1. PubMed ID: 19560667
    [No Abstract]   [Full Text] [Related]  

  • 25. [Daptomycin--a new antibiotic for the treatment of skin and soft tissue infections].
    Mathiesen L; Midtvedt T; Solberg CO
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2383-4. PubMed ID: 16998552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Empirical antibiotic therapy of complicated skin and soft tissue infections in dermatological practice].
    Magyar A; Garaczi E; Hajdú E; Kemény L
    Orv Hetil; 2011 Feb; 152(7):252-8. PubMed ID: 21296734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin and soft tissue infection: frequency of aerobic bacterial isolates and their antimicrobial susceptibility pattern.
    Gupta V; Datta P; Singla N
    J Assoc Physicians India; 2008 May; 56():389-90. PubMed ID: 18700650
    [No Abstract]   [Full Text] [Related]  

  • 29. Complicated infections of skin and skin structures: when the infection is more than skin deep.
    DiNubile MJ; Lipsky BA
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii37-50. PubMed ID: 15150182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical guidelines developed by the STRAMA group in the county of Stockholm: skin and soft tissue infections].
    Lundbergh P
    Lakartidningen; 2001 Sep; 98(39):4202-5. PubMed ID: 11680155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficient antimicrobial chemotherapy for skin and soft tissue infections].
    Guchev IA; Sidorenko SV; Frantsuzov VN
    Antibiot Khimioter; 2003; 48(10):25-31. PubMed ID: 15004977
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of bacterial skin and soft tissue infections.
    Garlicki AM; Jawień M; Pancewicz S; Moniuszko-Malinowska A; Kalinowska-Nowak A; Bociąga-Jasik M
    Przegl Epidemiol; 2020; 74(1):89-107. PubMed ID: 32500989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections.
    Sader HS; Mallick R; Kuznik A; Fritsche TR; Jones RN
    Int J Antimicrob Agents; 2007 Dec; 30(6):514-20. PubMed ID: 17959359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
    Stryjewski ME; O'Riordan WD; Lau WK; Pien FD; Dunbar LM; Vallee M; Fowler VG; Chu VH; Spencer E; Barriere SL; Kitt MM; Cabell CH; Corey GR;
    Clin Infect Dis; 2005 Jun; 40(11):1601-7. PubMed ID: 15889357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial skin and soft tissue infections in older adults.
    Compton GA
    Clin Geriatr Med; 2013 May; 29(2):443-59. PubMed ID: 23571039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
    Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH
    Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin and soft tissue infections.
    Roberts SA; Lang SD
    N Z Med J; 2000 May; 113(1109):164-7. PubMed ID: 10894343
    [No Abstract]   [Full Text] [Related]  

  • 40. High prevalence rate of multidrug resistance among nosocomial pathogens in the respiratory care center of a tertiary hospital.
    Lee CM; Yeh SC; Lim HK; Liu CP; Tseng HK
    J Microbiol Immunol Infect; 2009 Oct; 42(5):401-4. PubMed ID: 20182669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.